Stock

BioAge Labs, Inc. BIOA

$21.77-0.43%

All stocks Create account to unlock

Overview

BIOA market data

Price History

BIOA price chart

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for BIOA. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

9 captured

BioAge Labs Announces First Participant Dosed in QUELL-CV, a Phase 2 Proof-of-Concept Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Patients at Elevated Cardiovascular Risk · Jun 16, 2026, 12:15 PM

BioAge Labs Doses First Participant Dosed In QUELL-CV · Jun 16, 2026, 12:05 PM

This GE Aerospace Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday · May 27, 2026, 11:43 AM

Roth Capital Initiates Coverage On Bioage Labs with Buy Rating, Announces Price Target of $36 · May 27, 2026, 10:08 AM

BioAge Labs to Present at Upcoming Investor Conferences · May 22, 2026, 1:15 PM

Cell-Based Therapies Poised to Disrupt Multi-Billion-Dollar Anti-Aging and Neurodegenerative Markets · May 20, 2026, 2:15 PM

This CoinShares Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Wednesday · May 13, 2026, 5:43 PM

BTIG Initiates Coverage On Bioage Labs with Buy Rating, Announces Price Target of $40 · May 13, 2026, 10:17 AM

8-K filing — BioAge Labs, Inc. (BIOA) · May 8, 2026, 1:10 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock